ReNeuron Group (RENE)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.38p
   
  • Change Today:
      0.000p
  • 52 Week High: 11.13
  • 52 Week Low: 3.38
  • Currency: UK Pounds
  • Shares Issued: 57.17m
  • Volume: 0
  • Market Cap: £1.93m
  • RiskGrade: 394

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
55.67% above the market average55.67% above the market average55.67% above the market average55.67% above the market average55.67% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
16.52% above the market average16.52% above the market average16.52% above the market average16.52% above the market average16.52% above the market average
3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average
Price Book Ratio
79.81% above the market average79.81% above the market average79.81% above the market average79.81% above the market average79.81% above the market average
87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
4.33% below the market average4.33% below the market average4.33% below the market average4.33% below the market average4.33% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Chg 3m
64.15% below the market average64.15% below the market average64.15% below the market average64.15% below the market average64.15% below the market average
8.77% above the sector average8.77% above the sector average8.77% above the sector average8.77% above the sector average8.77% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
92.57% below the market average92.57% below the market average92.57% below the market average92.57% below the market average92.57% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
82.75% below the market average82.75% below the market average82.75% below the market average82.75% below the market average82.75% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
86.48% below the market average86.48% below the market average86.48% below the market average86.48% below the market average86.48% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Operating Profit Loss
76.08% below the market average76.08% below the market average76.08% below the market average76.08% below the market average76.08% below the market average
37.04% below the sector average37.04% below the sector average37.04% below the sector average37.04% below the sector average37.04% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
38.41% below the market average38.41% below the market average38.41% below the market average38.41% below the market average38.41% below the market average
Sector averageSector averageSector averageSector averageSector average
Cash
8.05% below the market average8.05% below the market average8.05% below the market average8.05% below the market average8.05% below the market average
7.41% above the sector average7.41% above the sector average7.41% above the sector average7.41% above the sector average7.41% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
46.34% below the market average46.34% below the market average46.34% below the market average46.34% below the market average46.34% below the market average
61.29% below the sector average61.29% below the sector average61.29% below the sector average61.29% below the sector average61.29% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

ReNeuron Group Market Data

Currency UK Pounds
Share Price 3.38p
Change Today 0.000p
% Change 0.00 %
52 Week High 11.13
52 Week Low 3.38
Volume 0
Shares Issued 57.17m
Market Cap £1.93m
RiskGrade 394

ReNeuron Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.64% above the market average69.64% above the market average69.64% above the market average69.64% above the market average69.64% above the market average
5.66% above the sector average5.66% above the sector average5.66% above the sector average5.66% above the sector average5.66% above the sector average
Price Trend
91.63% below the market average91.63% below the market average91.63% below the market average91.63% below the market average91.63% below the market average
64.91% below the sector average64.91% below the sector average64.91% below the sector average64.91% below the sector average64.91% below the sector average
Income Not Available
Growth
6.10% above the market average6.10% above the market average6.10% above the market average6.10% above the market average6.10% above the market average
2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ReNeuron Group Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Top of Page